Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Today at 5pm
India's Top 3 Smallcap
Stocks Revealed




**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a Free-for-life newsletter from Equitymaster,
which offers the most profitable investing ideas in India.


AD

METROPOLIS HEALTHCARE 2021-22 Annual Report Analysis
Wed, 3 Aug

METROPOLIS HEALTHCARE has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

METROPOLIS HEALTHCARE Income Statement Analysis

  • Operating income during the year rose 23.1% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 25.6% YoY during the fiscal. Operating profit margins witnessed a fall and down at 29.6% in FY22 as against 29.0% in FY21.
  • Depreciation charges increased by 37.6% and finance costs increased by 116.5% YoY, respectively.
  • Other income grew by 46.3% YoY.
  • Net profit for the year grew by 17.1% YoY.
  • Net profit margins during the year declined from 18.4% in FY21 to 17.5% in FY22.

METROPOLIS HEALTHCARE Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 9,980 12,283 23.1%
Other income Rs m 120 176 46.3%
Total Revenues Rs m 10,100 12,460 23.4%
Gross profit Rs m 2,898 3,640 25.6%
Depreciation Rs m 459 632 37.6%
Interest Rs m 116 250 116.5%
Profit before tax Rs m 2,443 2,934 20.1%
Tax Rs m 610 787 29.0%
Profit after tax Rs m 1,833 2,147 17.1%
Gross profit margin % 29.0 29.6
Effective tax rate % 25.0 26.8
Net profit margin % 18.4 17.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today at 5 PM: India's Top 3 Smallcap Stocks Revealed

METROPOLIS HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 3 billion as compared to Rs 2 billion in FY21, thereby witnessing an increase of 42.6%.
  • Long-term debt stood at Rs 2 billion as compared to Rs 0 million during FY21, a fall of 0.0%.
  • Current assets fell 33% and stood at Rs 4 billion, while fixed assets rose 180% and stood at Rs 12 billion in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 16 billion as against Rs 11 billion during FY21, thereby witnessing a growth of 50%.

METROPOLIS HEALTHCARE Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 6,981 8,744 25.3
 
Current Liabilities Rs m 2,402 3,424 42.6
Long-term Debt Rs m 0 1,587 0.0
Total Liabilities Rs m 10,592 15,927 50.4
 
Current assets Rs m 6,447 4,340 -32.7
Fixed Assets Rs m 4,145 11,587 179.6
Total Assets Rs m 10,592 15,927 50.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



METROPOLIS HEALTHCARE Cash Flow Statement Analysis

  • METROPOLIS HEALTHCARE's cash flow from operating activities (CFO) during FY22 stood at Rs 3 billion, an improvement of 1.7% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -7 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs 2 billion, an improvement of 597% on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs -3 billion from the Rs 3 billion net cash flows seen during FY21.

METROPOLIS HEALTHCARE Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 2,490 2,533 1.7%
Cash Flow from Investing Activities Rs m 617 -7,376 -
Cash Flow from Financing Activities Rs m -327 1,625 -
Net Cash Flow Rs m 2,794 -3,206 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for METROPOLIS HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 42.0, an improvement from the EPS of Rs 35.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,552.5, stands at 37.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 9.1 times, while the price to sales ratio stands at 6.5 times.
  • The company's price to cash flow (P/CF) ratio stood at 49.6 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 195.2 240.1
TTM Earnings per share Rs 35.9 42.0
Diluted earnings per share Rs 35.8 41.9
Price to Cash Flow x 50.0 49.6
TTM P/E ratio x 62.6 37.0
Price / Book Value ratio x 12.8 15.8
Market Cap Rs m 89,325 137,766
Dividends per share (Unadj.) Rs 8.0 8.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for METROPOLIS HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.3x during FY22, from 2.7x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 12.7x during FY22, from 22.1x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 24.6% during FY22, from 26.3% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 30.8% during FY22, from 36.7% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 15.1% during FY22, from 18.4% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 2.7 1.3
Debtors’ Days Days 450 403
Interest coverage x 22.1 12.7
Debt to equity ratio x 0.0 0.2
Return on assets % 18.4 15.1
Return on equity % 26.3 24.6
Return on capital employed % 36.7 30.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how METROPOLIS HEALTHCARE has performed over the last 5 years, please visit here.

METROPOLIS HEALTHCARE Share Price Performance

Over the last one year, METROPOLIS HEALTHCARE share price has moved down from Rs 2,950.6 to Rs 1,552.5, registering a loss of Rs 1,398.1 or around 47.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 22,818.4 (down 0.6%). Over the last one year it has moved down from 26,528.5 to 22,818.4, a loss of 3,710 points (down 14.0%).

Overall, the S&P BSE SENSEX is up 10.3% over the year.

(To know more, check out historical annual results for METROPOLIS HEALTHCARE and quarterly results for METROPOLIS HEALTHCARE)

Annual Report FAQs

What is the current share price of METROPOLIS HEALTHCARE?

METROPOLIS HEALTHCARE currently trades at Rs 0.0 per share. You can check out the latest share price performance of METROPOLIS HEALTHCARE here...

What was the revenue of METROPOLIS HEALTHCARE in FY22? How does it compare to earlier years?

The revenues of METROPOLIS HEALTHCARE stood at Rs 12,460 m in FY22, which was up 23.4% compared to Rs 10,100 m reported in FY21.

METROPOLIS HEALTHCARE's revenue has grown from Rs 6,549 m in FY18 to Rs 12,460 m in FY22.

Over the past 5 years, the revenue of METROPOLIS HEALTHCARE has grown at a CAGR of 17.4%.

What was the net profit of METROPOLIS HEALTHCARE in FY22? How does it compare to earlier years?

The net profit of METROPOLIS HEALTHCARE stood at Rs 2,147 m in FY22, which was up 17.1% compared to Rs 1,833 m reported in FY21.

This compares to a net profit of Rs 1,281 m in FY20 and a net profit of Rs 1,250 m in FY19.

Over the past 5 years, METROPOLIS HEALTHCARE net profit has grown at a CAGR of 17.7%.

What does the cash flow statement of METROPOLIS HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of METROPOLIS HEALTHCARE reveals:

  • Cash flow from operations increased in FY22 and stood at Rs 2,533 m as compared to Rs 2,490 m in FY21.
  • Cash flow from investments decreased in FY22 and stood at Rs -7,376 m as compared to Rs 617 m in FY21.
  • Cash flow from financial activity increased in FY22 and stood at Rs 1,625 m as compared to Rs -327 m in FY21.

Here's the cash flow statement of METROPOLIS HEALTHCARE for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations1,0399022,1502,4902,533
From Investments19353-1,048617-7,376
From Financial Activity-873-1,181-553-3271,625
Net Cashflow180795582,794-3,206

What does the Key Ratio analysis of METROPOLIS HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of METROPOLIS HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and down at 29.6% in FY22 as against 29.0% in FY21.
  • Net profit margins declined from 18.4% in FY21 to 17.5% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.2 as compared to 0.0 in FY21.

Here's the ratio/financial analysis of METROPOLIS HEALTHCARE for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)27.626.824.829.029.6
Net Profit Margin (%)17.316.415.018.417.5
Debt to Equity Ratio (x)0.00.00.00.00.2

Equitymaster requests your view! Post a comment on "METROPOLIS HEALTHCARE 2021-22 Annual Report Analysis". Click here!